COVID-19 RESPONSE - We are committed to supporting our scientific community during this pandemic. Learn more 

The Fred Hutch Cancer Research Center uses the ClonePix 2 system to efficiently screen and isolate positive hybridoma clones

Fred Hutch Cancer Research Center

Ben Hoffstrom, PfD, Director of Antibody Technology

ClonePix 2 Mammalian Colony Picker

The Challenge

The Antibody Technology Shared Resource at the Fred Hutch Cancer Research Center offers custom antibody development to academic and industrial research groups. Our unique multiplex screening platform incorporates a Molecular Devices ClonePix 2 for identifying and picking monoclonal hybridoma colonies that secrete antibody to specific protein, peptide, or small molecule targets. The ClonePix 2 has allowed us to completely redefine our project workflow and capacity.

The Fred Hutch Cancer Research Center uses ClonePix 2 System